20th Oct 2020 08:00
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,613,951 | 2.03% | 467,354 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
544,656 | 0.42% | 438,524 | 0.34% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,158,607 | 2.45% | 905,878 | 0.70% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 15 | 215.6500 USD |
Purchase | 30 | 210.6800 USD |
Purchase | 60 | 215.3858 USD |
Purchase | 76 | 215.7822 USD |
Purchase | 98 | 215.6481 USD |
Purchase | 100 | 211.2900 USD |
Purchase | 104 | 215.9919 USD |
Purchase | 114 | 215.2622 USD |
Purchase | 154 | 214.6063 USD |
Purchase | 226 | 215.6954 USD |
Purchase | 279 | 216.5900 USD |
Purchase | 282 | 215.6777 USD |
Purchase | 303 | 216.4119 USD |
Purchase | 356 | 215.7297 USD |
Purchase | 477 | 215.9793 USD |
Purchase | 555 | 216.2790 USD |
Purchase | 1,035 | 216.1455 USD |
Purchase | 1,268 | 212.6784 USD |
Purchase | 1,509 | 216.3408 USD |
Purchase | 1,633 | 216.1404 USD |
Purchase | 1,733 | 216.0841 USD |
Purchase | 2,013 | 216.1770 USD |
Purchase | 2,593 | 216.2227 USD |
Purchase | 2,662 | 216.1819 USD |
Purchase | 3,071 | 215.6125 USD |
Purchase | 3,076 | 216.1215 USD |
Purchase | 3,613 | 216.1585 USD |
Purchase | 4,612 | 216.6200 USD |
Purchase | 7,388 | 216.1729 USD |
Purchase | 9,100 | 216.0907 USD |
Purchase | 9,621 | 215.5544 USD |
Purchase | 14,507 | 216.5546 USD |
Purchase | 21,419 | 216.2183 USD |
Purchase | 22,502 | 215.6244 USD |
Purchase | 27,224 | 215.8209 USD |
Sale | 5 | 216.0600 USD |
Sale | 30 | 210.6800 USD |
Sale | 70 | 209.9900 USD |
Sale | 100 | 211.2900 USD |
Sale | 112 | 216.3146 USD |
Sale | 191 | 213.8842 USD |
Sale | 499 | 216.4488 USD |
Sale | 525 | 216.5246 USD |
Sale | 668 | 215.8456 USD |
Sale | 714 | 215.3228 USD |
Sale | 790 | 216.3718 USD |
Sale | 800 | 216.1583 USD |
Sale | 1,134 | 214.5879 USD |
Sale | 1,163 | 216.0689 USD |
Sale | 1,268 | 212.6784 USD |
Sale | 1,270 | 215.3585 USD |
Sale | 1,699 | 216.3468 USD |
Sale | 1,859 | 215.6626 USD |
Sale | 2,291 | 214.4131 USD |
Sale | 7,518 | 215.7353 USD |
Sale | 8,211 | 216.3647 USD |
Sale | 8,473 | 216.0440 USD |
Sale | 8,536 | 215.6037 USD |
Sale | 8,757 | 215.6775 USD |
Sale | 11,735 | 216.6200 USD |
Sale | 24,765 | 215.8417 USD |
Sale | 50,009 | 216.1925 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
SWAP | Short | 50,000 | 216.2225 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 20 Oct 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005945/en/
Copyright Business Wire 2020
Related Shares:
Barclays